News Banner

MaxQ AI leads AI security with ISO 27799 certification for health informatics

Information Security and ISO 27001 Recertification

New healthcare information security certification demonstrates commitment to the highest standards of data protection across the company’s operations, systems, and products.

Tel Aviv, Israel – December 2nd, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today that after undergoing stringent reviews by the British Standards Institution (BSI), it has achieved ISO 27799 certification and ISO 27001 recertification. Both certifications are widely recognized international standards for information security management systems. These standards separate MaxQ in its commitment to deploying the Accipio Clinical Platform as a comprehensive, seamless, and secure solution for the healthcare industry.

MaxQ’s ISO 27001 and 27799 certifications attest to its commitment to securing development lifecycle management, data integrity, and privacy. “Although ISO 27001 certification is not required by any regulatory body at this time, MaxQ AI chose to pursue these ISO standards because of the importance of providing secure healthcare solutions while adhering to the highest industry security standards. Our mission is patient safety, and we see security as part of that mission” said Robert Mehler, Co-Founder, Chief Operating Officer, and Chief Information Security Officer for MaxQ AI. “Cybersecurity is a threat that goes far beyond lost revenue and expenses. An attack can have dire, potentially irreparable consequences for patient care, and to the healthcare organization’s reputation.”

The Accipio Clinical Platform generates multiple insights into a patient’s medical imaging study that may help provide a faster and clinically accurate diagnosis of Intracranial Hemorrhage (ICH) in acute care settings across the globe. There is a stroke patient every 40 seconds in the USA and ICH accounts for approximately 20% of all strokes and presents in up to 30% of all head injuries*. The platform is comprised of Accipio Ix (Intracranial Hemorrhage (ICH) triage and notification, Accipio Ax (Slice-Level Annotation), and Accipio Dxg (Triage for ICH Presence or Absence)**.
MaxQ is the only AI platform company offering advanced AI applications and AI platform solutions, such as MaxQ Xpress, as a seamless, integrated offering, secured through ISO 27001 and ISO 27799 cybersecurity standards.

Willy Fabritius, Global Head Information Security and Business Continuity at BSI comments: “Protecting data has become increasingly challenging for organizations, this is why it’s a huge achievement for MaxQ to have been certified against these Management System standards as it shows the organization’s proactive approach to managing information security and building resilience for the future.”

Accipio devices are globally available with multiple regulatory approvals and seamlessly deployed through MaxQ’s trusted channel partner base, including GE, Philips, Nuance, FujiFilm, Blackford, IBM Watson Health, and TeraRecon. Radiology Departments, Emergency Room, and Neuroradiology teams utilize Accipio to make treatment path decisions while lessening burden and burn-out. MaxQ’s Accipio platform can be viewed at the 106th RSNA virtual exhibit through its unique AI experience within each of the MaxQ channel partners.

About MaxQ AI, Ltd.

MaxQ AI is transforming healthcare by empowering physicians to provide ‘smarter care’ with enhanced clinical workflow solutions assisting with improved patient triage and artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel, and Andover, MA our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing intracranial hemorrhage, stroke, brain trauma, and other serious conditions. To learn more, visit or follow us on LinkedIn.